FDA Warns Infant Formula Manufacturers After Botulism Outbreaks and Contaminated Ingredient Investigations

FDA Issues Urgent Warning to Infant Formula Industry Following Serious Safety Incidents

What Parker Waichman LLP Found

• The FDA investigated two separate multi-state infant botulism outbreaks linked to powdered infant formula.
• The ByHeart outbreak was the first confirmed U.S. infant formula-related botulism outbreak in nearly 50 years.
• Regulators also investigated a separate outbreak involving Nara Organics formula products.
• A global contamination event involving cereulide-tainted arachidonic acid oil reportedly affected nearly 150 suspected and confirmed cases across ten countries.
• Families whose children were harmed by contaminated infant formula may have legal rights through product liability claims.

The U.S. Food and Drug Administration has issued a significant warning to infant formula manufacturers, distributors, importers, retailers, and supply-chain partners after multiple product recalls, infant botulism outbreaks, and contamination incidents raised concerns about the safety of formula products sold to families across the United States.

According to the FDA, the agency has investigated two separate multi-state infant botulism outbreaks connected to powdered infant formula products sold under different brands. These outbreaks resulted in recalls and have triggered renewed scrutiny of ingredient sourcing, supplier oversight, contamination controls, and quality assurance practices throughout the infant formula industry.

The FDA’s warning comes at a time when parents continue to depend on infant formula as a critical source of nutrition for newborns and young children. Unlike many consumer products, infant formula is often the sole source of nourishment for babies during the earliest and most vulnerable stages of life. Because infants have developing immune systems and limited ability to fight infections, even small amounts of contamination can create serious health risks.

Federal regulators emphasized that manufacturers must understand where ingredients originate, how they are processed, what contamination risks may exist, and whether adequate safeguards are in place to prevent dangerous substances from reaching finished products. The agency’s concerns extend beyond a single manufacturer or recall and instead focus on systemic risks within portions of the infant formula supply chain.

For families whose children suffered illness, hospitalization, long-term complications, or other injuries after consuming contaminated infant formula, the FDA’s findings may raise important questions regarding accountability and potential legal claims.

Understanding the FDA’s Concerns About Infant Formula Safety

The FDA’s public communication reflects concerns that recent contamination events may indicate broader weaknesses in supplier oversight and ingredient monitoring within portions of the infant formula industry.

Federal regulators stated that manufacturers should maintain substantive oversight of suppliers and remain alert to recall notices, outbreak investigations, import alerts, and other safety warnings that may affect ingredients used in infant nutrition products.

The agency’s position is significant because infant formula manufacturers often rely on complex international supply chains involving multiple ingredient suppliers, processors, transportation companies, testing laboratories, and packaging facilities.

When one component of that system fails, contamination can potentially spread across large numbers of products distributed nationwide or internationally.

The FDA specifically highlighted the importance of manufacturers understanding:

• Where ingredients originate
• How ingredients are produced
• Whether contamination risks exist
• Whether risks are properly controlled
• Whether suppliers maintain adequate safety procedures
• Whether emerging safety concerns are identified promptly

Failures at any stage of production can expose infants to dangerous pathogens, toxins, or contaminants capable of causing severe illness.

Because infant formula is consumed by some of the most medically vulnerable individuals in society, regulators generally expect exceptionally high safety standards throughout the manufacturing process.

The ByHeart Infant Formula Botulism Outbreak

One of the most significant developments discussed by the FDA involves the 2025 infant botulism outbreak associated with ByHeart infant formula.

According to the agency, this outbreak marked the first confirmed infant formula-related botulism outbreak in the United States in nearly fifty years.

Botulism is a rare but potentially life-threatening illness caused by toxins produced by Clostridium botulinum bacteria. The toxin attacks the nervous system and can interfere with muscle function, breathing, swallowing, and movement.

Infants are particularly vulnerable because their digestive systems are not fully developed.

Symptoms of infant botulism may include:

• Weak crying
• Poor feeding
• Constipation
• Lethargy
• Muscle weakness
• Difficulty swallowing
• Respiratory distress
• Paralysis

Without prompt medical intervention, botulism can become fatal.

The FDA’s confirmation that a formula-related outbreak occurred after nearly five decades without a similar event has prompted significant concern among public health officials and consumer advocates.

Investigators continue examining how contamination occurred and whether preventable failures contributed to the outbreak.

Nara Organics Recall and Additional Botulism Investigations

The FDA also investigated a separate multi-state infant botulism outbreak associated with Nara Organics powdered infant formula.

The existence of two separate outbreaks involving different formula brands within a relatively short period has intensified concerns regarding ingredient sourcing and manufacturing controls.

When multiple outbreaks occur involving separate products, investigators often examine whether common suppliers, shared ingredients, similar manufacturing practices, or systemic quality-control weaknesses may have played a role.

Although federal investigators continue examining the root causes of these incidents, the agency’s warning indicates that regulators believe stronger supplier oversight may be necessary throughout the industry.

Parents understandably expect infant formula manufacturers to maintain rigorous testing and safety protocols. The occurrence of multiple outbreaks linked to formula products raises difficult questions regarding contamination prevention, detection procedures, and post-market monitoring systems.

For families affected by recalled products, the consequences can include hospitalization, extensive medical treatment, emotional trauma, and concerns about future health complications.

The International Cereulide Contamination Event

The FDA also referenced a major international contamination event that occurred between late 2025 and early 2026.

According to regulators, nearly 150 suspected and confirmed cases of cereulide intoxication were identified across ten countries. Investigators traced the contamination to arachidonic acid oil used as an ingredient in infant formula products.

Cereulide is a toxin produced by certain strains of Bacillus cereus bacteria. Unlike many contaminants that cause relatively mild gastrointestinal symptoms, cereulide can present serious health risks under certain circumstances.

Exposure may result in symptoms such as:

• Nausea
• Vomiting
• Abdominal pain
• Dehydration
• Serious illness requiring hospitalization

Infants may face heightened risks because of their small body size and developing organ systems.

The fact that a single contaminated ingredient was reportedly connected to cases spanning multiple countries illustrates how ingredient-related contamination events can quickly become global public health concerns.

When contamination originates within a commonly used ingredient, multiple manufacturers and product lines may be affected before the problem is identified and contained.

A2 Milk Formula Recall Adds to Growing Industry Concerns

The FDA also referenced a recall involving a2 Milk’s a2 Platinum infant formula.

In May 2026, the company recalled three batches of formula sold in the United States after detecting cereulide contamination.

Although recalls are intended to protect consumers by removing potentially dangerous products from circulation, recalls also demonstrate that contamination can occur despite existing safety measures.

Parents often assume infant formula products undergo extensive testing before reaching store shelves. While testing requirements exist, contamination incidents continue to occur across various segments of the food and nutrition industry.

Each recall prompts investigators to examine whether earlier intervention could have prevented the distribution of potentially hazardous products.

When infants become ill after consuming contaminated formula, families may face significant medical expenses and emotional distress while trying to understand how a product intended to nourish their child became a source of harm.

Why Supplier Oversight Is Critical in Infant Formula Manufacturing

The FDA’s warning repeatedly emphasizes supplier oversight because ingredient suppliers often represent one of the earliest opportunities to identify contamination risks.

Modern infant formula production involves numerous ingredients sourced from multiple locations around the world. Manufacturers may rely on suppliers for oils, proteins, vitamins, minerals, carbohydrates, and specialty nutritional compounds.

Effective supplier oversight may include:

• Ingredient testing programs
• Supplier audits
• Manufacturing inspections
• Quality assurance reviews
• Contamination monitoring
• Import screening
• Traceability systems
• Corrective action procedures

When oversight systems fail, contaminated ingredients can move through the supply chain undetected.

The FDA’s letter suggests regulators believe stronger monitoring and accountability measures may be necessary to prevent future outbreaks and contamination events.

Potential Lawsuits Involving Contaminated Infant Formula

Families whose children suffered injuries after consuming contaminated infant formula may have legal rights under product liability laws.

Product liability claims often focus on whether manufacturers, distributors, suppliers, or other entities failed to provide reasonably safe products for consumers.

Potential legal claims may involve:

• Defective product allegations
• Manufacturing defects
• Negligence
• Failure to test
• Failure to identify contamination
• Failure to warn consumers
• Supply-chain negligence
• Breach of warranty

A successful claim may seek compensation for:

• Medical expenses
• Hospitalization costs
• Long-term treatment
• Future medical care
• Pain and suffering
• Emotional distress
• Developmental complications
• Wrongful death damages when applicable

Each case depends on its own facts, including the nature of the contamination, the injuries involved, and the evidence connecting the illness to a particular product.

What Parents Should Do if Their Child Consumed a Recalled Formula Product

Parents who believe their child consumed recalled or potentially contaminated infant formula should seek appropriate medical evaluation if symptoms develop.

They should also consider preserving important evidence, including:

• Formula containers
• Batch numbers
• Purchase receipts
• Medical records
• Hospital records
• Product packaging
• Recall notices

Documentation can be important when determining whether contamination may have contributed to an infant’s illness.

Families should also monitor recall announcements and FDA safety communications involving products their children consume.

Infant Formula Lawsuit FAQs

Can parents file a lawsuit if their child became ill after consuming contaminated infant formula?

Potentially yes. If contaminated formula caused illness, hospitalization, developmental complications, or other injuries, families may have grounds to pursue legal claims. Product liability cases typically focus on whether contamination occurred because of manufacturing failures, inadequate testing, negligent quality control, or other preventable issues.

What is infant botulism?

Infant botulism is a rare but potentially life-threatening illness caused by toxins produced by Clostridium botulinum bacteria. The toxin attacks the nervous system and can interfere with breathing, feeding, muscle control, and movement. Infants often require immediate medical attention because the condition can progress rapidly.

Does a product recall automatically mean a manufacturer is liable?

Not necessarily. A recall does not automatically establish legal liability. However, recalls can serve as important evidence in investigations involving contaminated products. Attorneys often examine recall records, testing data, internal communications, regulatory findings, and other evidence when evaluating potential claims.

Who can be held responsible in an infant formula lawsuit?

Depending on the circumstances, potentially responsible parties may include manufacturers, ingredient suppliers, distributors, testing laboratories, importers, and other entities involved in the production and distribution process. Investigations frequently focus on the entire supply chain to determine where contamination originated and whether it could have been prevented.

What damages may be available in a contaminated formula case?

Compensation may include medical expenses, hospitalization costs, rehabilitation expenses, future medical care, pain and suffering, emotional distress, and other losses resulting from the child’s illness. In severe cases involving permanent injuries, damages may also include future care needs and developmental support services.

How do investigators determine whether a formula caused an illness?

Investigators often review medical records, laboratory testing, epidemiological data, recall information, batch numbers, product samples, and regulatory findings. Establishing a connection between the illness and a specific product is frequently one of the most important aspects of a product liability case.

What should parents do if they still have recalled formula?

Parents should follow FDA and manufacturer recall instructions immediately. Preserving unopened containers, packaging, lot numbers, and receipts may also be important if legal claims are later pursued.

Was Your Child Harmed by Contaminated Infant Formula? Contact Parker Waichman LLP Today.

Parents trust infant formula manufacturers to provide safe nutrition for their children. When contamination, inadequate testing, or supply-chain failures place infants at risk, families deserve answers and accountability.

If your child became ill after consuming recalled or contaminated infant formula, you may have important legal rights. Medical expenses, hospitalization costs, long-term health complications, and emotional trauma can create significant burdens for families already facing difficult circumstances.

Parker Waichman LLP represents families nationwide in product liability litigation involving dangerous consumer products, contaminated food products, and infant formula injuries. Parker Waichman LLP offers free consultations to families seeking information about their legal options.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free case evaluation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.